Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents

被引:29
|
作者
Francis, Stuart [1 ]
Croft, Daniel [1 ]
Schtittelkopf, Alexander W. [1 ]
Parry, Charles [1 ]
Pughese, Angelo [1 ]
Cameron, Ken [1 ]
Claydon, Sophie [1 ]
Drysdale, Martin [1 ,4 ]
Gardner, Claire [1 ]
Gohlke, Andrea [1 ]
Goodwin, Gillian [1 ]
Gray, Christopher H. [1 ]
Konczal, Jennifer [1 ]
McDonald, Laura [1 ]
Mezna, Mokdad [1 ]
Pannifer, Andrew [1 ,5 ]
Paul, Nikki R. [2 ]
Machesky, Laura [2 ,3 ]
McKinnon, Heather [1 ]
Bower, Justin [1 ]
机构
[1] CRUK Beatson Inst, Drug Discovery Unit, Glasgow G61 1BD, Lanark, Scotland
[2] CRUK Beatson Inst, Cell Migrat Lab, Glasgow G61 1BD, Lanark, Scotland
[3] Univ Glasgow, Inst Canc Sci, Glasgow G61 1QH, Lanark, Scotland
[4] Broad Inst, Cambridge, MA 02142 USA
[5] Med Discovery Catapult, Alderly Pk, Alderley Edge SK10 4TG, England
关键词
Virtual screening; Fragments; Drug discovery; Medicinal chemistry; Cancer; LIGAND; CANCER;
D O I
10.1016/j.bmcl.2019.01.035
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Fascin is an actin binding and bundling protein that is not expressed in normal epithelial tissues but overexpressed in a variety of invasive epithelial tumors. It has a critical role in cancer cell metastasis by promoting cell migration and invasion. Here we report the crystal structures of fascin in complex with a series of novel and potent inhibitors. Structure-based elaboration of these compounds enabled the development of a series with nanomolar affinities for fascin, good physicochemical properties and the ability to inhibit fascin-mediated bundling of filamentous actin. These compounds provide promising starting points for fascin-targeted anti-metastatic therapies.
引用
收藏
页码:1023 / 1029
页数:7
相关论文
共 50 条
  • [1] Structure-based design, synthesis, and evaluation of 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel c-Met inhibitors
    Zhang, Li
    Zhang, Beichen
    Zhao, Jingyun
    Zhi, Yanle
    Wang, Lu
    Lu, Tao
    Chen, Yadong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 138 : 942 - 951
  • [2] Structure-based Design, Synthesis, and Biological Evaluation of Isatin Derivatives as Potential Glycosyltransferase Inhibitors
    Wang, Yong
    Chan, Fung-Yi
    Sun, Ning
    Lui, Hok-Kiu
    So, Pui-Kin
    Yan, Siu-Cheong
    Chan, Kin-Fai
    Chiou, Jiachi
    Chen, Sheng
    Abagyan, Ruben
    Leung, Yun-Chung
    Wong, Kwok-Yin
    CHEMICAL BIOLOGY & DRUG DESIGN, 2014, 84 (06) : 685 - 696
  • [3] Design, Synthesis and Biological Evaluation of Novel Pyrazolo[1,2,4]triazolopyrimidine Derivatives as Potential Anticancer Agents
    Aliwaini, Saeb
    Abu Thaher, Bassam
    Al-Masri, Ihab
    Shurrab, Nabil
    El-Kurdi, Said
    Schollmeyer, Dieter
    Qeshta, Basem
    Ghunaim, Mariam
    Csuk, Rene
    Laufer, Stefan
    Kaiser, Lars
    Deigner, Hans-Peter
    MOLECULES, 2021, 26 (13):
  • [4] Synthesis and biological evaluation of new [1,2,4]triazolo[4,3-a]pyridine derivatives as potential c-Met inhibitors
    Zhao, Junjun
    Fang, Lei
    Zhang, Xiaobing
    Liang, Yan
    Gou, Shaohua
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (16) : 3483 - 3493
  • [5] Design, synthesis and biological evaluation of novel chromeno[4,3-c] pyrazol-4(2H)-one derivates containing sulfonamido as potential PI3Kα inhibitors
    Yin, Yong
    Hu, Jia-Qin
    Wu, Xu
    Sha, Shao
    Wang, She-Feng
    Qiao, Fang
    Song, Zhong-Cheng
    Zhu, Hai-Liang
    BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (11) : 2261 - 2267
  • [6] Structure-based drug design, synthesis and screening of MmaA1 inhibitors as novel anti-TB agents
    Hymavathi Veeravarapu
    Vasavi Malkhed
    Kiran Kumar Mustyala
    Rajender Vadija
    Ramesh Malikanti
    Uma Vuruputuri
    Murali Krishna Kumar Muthyala
    Molecular Diversity, 2021, 25 : 351 - 366
  • [7] Structure-based drug design, synthesis and screening of MmaA1 inhibitors as novel anti-TB agents
    Veeravarapu, Hymavathi
    Malkhed, Vasavi
    Mustyala, Kiran Kumar
    Vadija, Rajender
    Malikanti, Ramesh
    Vuruputuri, Uma
    Muthyala, Murali Krishna Kumar
    MOLECULAR DIVERSITY, 2021, 25 (01) : 351 - 366
  • [8] A Novel Series of [1,2,4]Triazolo[4,3-a]Pyridine Sulfonamides as Potential Antimalarial Agents: In Silico Studies, Synthesis and In Vitro Evaluation
    Karpina, Veronika R.
    Kovalenko, Svitlana S.
    Kovalenko, Sergiy M.
    Drushlyak, Oleksandr G.
    Bunyatyan, Natalya D.
    Georgiyants, Victoriya A.
    Ivanov, Vladimir V.
    Langer, Thierry
    Maes, Louis
    MOLECULES, 2020, 25 (19):
  • [9] Identification of novel selective MMP-9 inhibitors as potential anti-metastatic lead using structure-based hierarchical virtual screening and molecular dynamics simulation
    Kalva, Sukesh
    Agrawal, Nikhil
    Skelton, Adam A.
    Saleena, Lilly M.
    MOLECULAR BIOSYSTEMS, 2016, 12 (08) : 2519 - 2531
  • [10] Discovery of a novel class anti-proliferative agents and potential inhibitors of EGFR tyrosine kinases based on 4-anilinotetrahydropyrido[4,3-d]pyrimidine scaffold: Design, synthesis and biological evaluations
    Zhang, Yong
    Zhang, Kai
    Zhao, Meng
    Zhang, Lixia
    Qin, Mingze
    Guo, Shuchun
    Zhao, Yanfang
    Gong, Ping
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (15) : 4591 - 4607